Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) is pleased to announce it has engaged the Thank You Merci’s sales and merchandising team (“TYM”) to represent Jusu Body, Jusu Life, and Jusu Juice; commencing immediately. TYM offers full-service sales representation and key account management for all channels in Canada & the USA. Better Plant already sells its wholly owned Jusu brands through its direct-to-consumer eCommerce platforms and is now augmenting those sales through retail channels.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/73630_1ca7f5e3b46df895_001.jpg


Better Plant’s Jusu Begins Expansion into U.S. Market

To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/6377/73630_1ca7f5e3b46df895_001full.jpg

Jusu Body consists of approximately 40 body and face products crafted from 100% plant-based ingredients. Jusu Life products include five home cleaning products with no chemicals that are also 100% plant-based. All products are available for purchase at getjusu.com. Jusu also has a proprietary line of all-natural pressed juices that are sold at the Jusu juice bar location at Cadboro Bay, Victoria and sold through direct-to-consumer platforms in Victoria, British Columbia and Calgary, Alberta.

TYM manages key accounts in the natural health and consumer packaged goods industry. The TYM team is composed of 10 experienced sales and account managers with over 16 years’ experience in the natural health industry.

“We are excited to be part of the launch and expansion of JUSU into the U.S. market. We feel we can help the brand explore direct and distributor partnerships with retailers from independent stores to national chains,” says TYM Founder and CEO, Lindsay Blakeman “Jusu products deliver high quality, innovative and on-trend products that we couldn’t be more thrilled to represent.”

Prior to founding Thank You Merci, Lindsay Blakeman worked with well-established brands such as Vega, Caulipower and Ancient Nutrition in both Canada and the U.S.

“Adding Thank You Merci’s esteemed sales and merchandising teams to represent Jusu products is a strategic move based on their extensive experience in the all-natural health and consumer packaged goods industry,” says Better Plant’s Head of Sales, Amber Allen. “The timing could not have been better with our entry into the U.S. market, to fully capitalize on their established relationships across North America.”

According to a report by Prophecy Market Insights, the global vegan beauty products market accounted for US$ 14.3 billion in 2019 and is estimated to be US$ 25.3 billion by 2029 and is anticipated to register a CAGR of 5.9%.

Jusu Life, Body and Home products are available in Canada at www.getjusu.com. For U.S. purchasing inquiries visit: www.thankyoumercisales.com.

About Better Plant Sciences Inc.

Better Plant offers plant-based products for optimum health and wellness. It is a vertically integrated company with a team whose complementary experience enables acquisition, development, manufacturing, and direct-to-consumer distribution of its products. Its all-natural products vary in use from pain treatment to disease prevention to skin care, all without chemicals or harmful ingredients. It has an extensive catalogue of over 400 proprietary product formulas. Better Plant currently has over 70 plant-based products for sale through eCommerce and/or in retail stores under the brands Jusu, Urban Juve, and Wright & Well. Better Plant also owns approximately 29.2% of NeonMind.

For more information on Better Plant, visit betterplantsciences.com or follow @betterplantsciences on Instagram.

Penny White, President & CEO
penny@betterplantsciences.com
1-833-515-2677

Investor Relations:
Alexandra Dumanski
invest@betterplantsciences.com
1-833-515-2677

Sales Inquiries:
Amber Allen
amber@betterplantsciences.com
604-808-8118

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward-looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies due to the spread of COVID-19, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company’s products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Better cautions readers not to place undue reliance on forward-looking statements provided by Better, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Better expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73630

News Provided by Newsfile via QuoteMedia

Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry

Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that effective January 4, 2021, it entered into a lab services agreement with Numinus Wellness Inc. (“Numinus“). Recognized as an early leader in developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), Numinus is aiding Optimi’s mission to further the research and development of Canadian-grown psilocybin-producing mushrooms and related product formulations.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis processor, is pleased to provide shareholders with the following corporate update:

Nextleaf Comments on Financial Results from Q1 Financials

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”) reported its second quarter results for the period ended December 31, 2020. A complete set of financial statements and Management’s Discussion & Analysis has been filed at www.sedar.com. All dollar figures are quoted in Canadian dollars.

The second quarter of FY21, saw continued momentum for the Company despite ongoing pandemic related challenges. Net revenue grew 8% to $745,748 from $689,276 versus the same quarter year ago. The Company also saw significant improvement on its bottom line, reducing its net loss by 50% from ($.956) million to ($.481) million, year over year for the quarter, as a result of improved gross margin and cost management efforts. On December 9, 2020, the company announced the closing of the acquisition of substantially all of the assets of Lexaria Canpharm (“Canpharm“), the cannabis products division of Lexaria Biosciences, resulting in the addition of a new B2B Line of Business.

Keep reading... Show less

Royalty Model Provides Access to Early Stage Licenced U.S. Cannabis Companies and Leverage to High-Margin Revenues

FinCanna Capital Corp. (“FinCanna” or the “Company”) (CSE:CALI), a royalty company for the licensed U.S. cannabis industry, is pleased to provide a corporate update further to its recently announced upsized financing of $2 million

Keep reading... Show less

Significant progress made as Numinus-sponsored PRIME study on psilocybin-assisted psychotherapy for opioid, stimulant and/or alcohol use disorders enters pre-implementation stage

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), and Syreon Corporation (Syreon), a global contract research organization with expertise in conducting clinical trials across a broad range of diseases, are pleased to share that significant progress has been made in the single-arm, open-label compassionate access 1 trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME) for substance use disorders. Currently in the development stage, the PRIME study will assess the efficacy and safety of psilocybin-assisted motivational enhancement therapy.

Keep reading... Show less